Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 195 (2) , 149-152
- https://doi.org/10.1016/s0022-510x(02)00009-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A genetic epidemiological study of spinocerebellar ataxias in Tottori prefecture, Japan.Neuroepidemiology, 2001
- Spinocerebellar ataxia type 6: founder effect in Western JapanJournal of the Neurological Sciences, 2001
- Branched-Chain Amino Acid Therapy for Spinocerebellar Degeneration: A Pilot Clinical Crossover Trial.Internal Medicine, 1999
- Close Associations between Prevalences of Dominantly Inherited Spinocerebellar Ataxias with CAG-Repeat Expansions and Frequencies of Large Normal CAG Alleles in Japanese and Caucasian PopulationsAmerican Journal of Human Genetics, 1998
- Brain metabolism of branched-chain amino acidsGlia, 1997
- Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6)Human Molecular Genetics, 1997
- International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndromeJournal of the Neurological Sciences, 1997
- Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channelNature Genetics, 1997
- Spinocerebellar degenerations in Japan: a nationwide epidemiological and clinical studyActa Neurologica Scandinavica, 1994
- Plasma Levels of Amino Acids Correlate With Motor Fluctuations in ParkinsonismArchives of Neurology, 1987